rawfin.tv
ADMA Biologics Director Purchases $100,125 in Company Stock
MarketsstocksAI Generated

ADMA Biologics Director Purchases $100,125 in Company Stock

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Dr. Jerrold B. Grossman, a director at ADMA Biologics, Inc., recently acquired 12,500 shares of the company's common stock. The transaction totaled $100,125, signaling insider confidence.

ADMAInsider BuyingBiotechnologyMarket SignalsHealthcare

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks